Fibrous dysplasia (monostotic), unspecified site digital illustration

Fibrous dysplasia (monostotic), unspecified site Save


ICD-10 code: M85.00

Disease category: M85.0: Fibrous dysplasia (monostotic)

Fibrous Dysplasia (Monostotic), Unspecified Site

Fibrous dysplasia is a rare bone disorder that primarily affects one bone or a limited number of bones. When the condition affects a single bone, it is referred to as monostotic fibrous dysplasia. Monostotic fibrous dysplasia can occur in various locations throughout the body, and in some cases, the site may remain unspecified.

Although the exact cause of fibrous dysplasia is unknown, researchers believe that it arises from a genetic mutation that occurs early in development. This mutation affects the normal process of bone formation, leading to the replacement of healthy bone tissue with fibrous tissue. The condition is not inherited and typically occurs sporadically.

While fibrous dysplasia can affect people of all ages, it is most commonly diagnosed in children and adolescents. The symptoms can vary depending on the location and extent of bone involvement. Common signs include bone pain, fractures, deformities, and limited range of motion. However, some individuals with monostotic fibrous dysplasia may not experience any symptoms at all.

Diagnosis of monostotic fibrous dysplasia involves a thorough medical history, physical examination, and imaging tests such as X-rays, CT scans, or MRIs. These tests help assess bone density, identify any lesions or deformities, and determine the extent of the condition.

  1. Treatment:
  2. Monitoring: In cases where monostotic fibrous dysplasia is asymptomatic or causes only mild symptoms, regular monitoring may be recommended to track the progression of the condition.
  3. Supportive Care: Treatment may involve managing symptoms through pain medications, physical therapy, and assistive devices to improve mobility.
  4. Surgical Intervention: In some instances, surgical intervention may be necessary to stabilize a fracture, correct deformities, or relieve pressure on nearby structures.

It is important to note that treatment options for fibrous dysplasia can vary depending on the individual's age, symptoms, and the specific bone(s) affected. Therefore, it is crucial to consult with a healthcare professional for an accurate diagnosis and personalized treatment plan.

In conclusion, fibrous dysplasia (monostotic), unspecified site is a rare bone disorder characterized by the replacement of healthy bone tissue with fibrous tissue. While it primarily affects a single bone or a limited number of bones, the exact site may remain unspecified. Early diagnosis and appropriate management are essential in optimizing the quality of life for individuals with this condition.

Treatment of Fibrous dysplasia (monostotic), unspecified site:

Treatment Options for Fibrous Dysplasia (Monostotic), Unspecified Site

Fibrous dysplasia is a rare bone disorder that primarily affects the long bones, skull, and facial bones. It occurs due to the abnormal development of fibrous tissue within the affected bones. Fibrous dysplasia is usually diagnosed during childhood or adolescence, but it can also be detected in adults.

W...

To see full information about treatment please Sign up or Log in